Ipca Laboratories consolidated net profit rises 18.07% in the June 2024 quarter

Net profit of Ipca Laboratories rose 18.07% to Rs 192.24 crore in the quarter ended June 2024 as against Rs 162.82 crore during the previous quarter ended June 2023. Sales rose 32.01% to Rs 2092.63 crore in the quarter ended June 2024 as against Rs 1585.21 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	2092.63	1585.21	32
OPM %	18.77	19.41	-
PBDT	389.28	321.09	21
PBT	290.39	251.82	15
NP	192.24	162.82	18